Boston Scientific Corporation (BSX) Financials
BSX Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| June 30, 2026 | 45.2 billion | 20.0 billion |
| March 31, 2026 | 44.4 billion | 18.2 billion |
| Dec. 31, 2025 | 43.7 billion | 19.2 billion |
| Sept. 30, 2025 | 42.7 billion | 19.1 billion |
BSX Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| June 30, 2026 | 1.3 billion | 87.0 million |
| March 31, 2026 | 171.0 million | 83.0 million |
| Dec. 31, 2025 | 1.0 billion | 71.0 million |
| Sept. 30, 2025 | 1.2 billion | 79.0 million |
BSX Net Income
Graph available only for paid members. Upgrade to see it.
| Date | Net Income |
|---|---|
| June 30, 2026 | 904.0 million |
| March 31, 2026 | 1.3 billion |
| Dec. 31, 2025 | 672.0 million |
| Sept. 30, 2025 | 755.0 million |
BSX Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| June 30, 2026 | 539.0 million | 10.8 billion | 124.0 million |
| March 31, 2026 | 1.5 billion | 10.9 billion | 124.0 million |
| Dec. 31, 2025 | 2.0 billion | 11.5 billion | 571.0 million |
| Sept. 30, 2025 | 1.3 billion | 11.0 billion | 570.0 million |
BSX Shares Outstanding
BSX Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| June 30, 2026 | 195.0 million | 554.0 million | 1.8 billion | - |
| March 31, 2026 | 177.0 million | 516.0 million | 1.8 billion | - |
| Dec. 31, 2025 | 351.0 million | 569.0 million | 1.8 billion | - |
| Sept. 30, 2025 | 181.0 million | 514.0 million | 1.7 billion | - |
BSX Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| June 30, 2026 | 5.4 billion | 1.6 billion |
| March 31, 2026 | 5.2 billion | 1.6 billion |
| Dec. 31, 2025 | 5.3 billion | 1.3 billion |
| Sept. 30, 2025 | 5.1 billion | 1.5 billion |
BSX Revenue by Segment
Graph available only for paid members. Upgrade to see it.
BSX
Price: $42.73
52 week price:
Payout Ratio Range:
Earnings Per Share: 2.47 USD
P/E Ratio: 19.61
Exchange: NYQ
Sector: Healthcare
Industry: Medical Devices
Country: United States
Volume: 13.0 million
Ebitda: 425.0 millionMarket Capitalization: 63.0 billion